|
SESSION
|
TOPIC
|
SPEAKER
|
OUTLINE
|
PRESENTATION
|
|
DAY ONE
|
|
1
|
Sustainable affordability in health care financing
& delivery
|
Bernard J Tyson, Senior Vice President, Brand Strategy
and Management, Kaiser Foundation Health Plan, Inc.
and Kaiser Foundation Hospitals
|
- Sustainable affordability in health care financing
and delivery from the perspective of Kaiser Permanente
- The challenges to sustainable health care financing
and delivery
- Achievement and current challenges of Kaiser Permanente
- Private sector solutions to affordable health
care delivery
- Improving the efficiency and quality of health
care
- Developing patient-centred care
- Implications for private health insurance in Australia
|
|
|
2
|
Sustainable affordability - Australian and New
Zealand experiences with Private Health Insurance
|
Professor Ian Harper, Executive Director, Melbourne
Business School
|
- The Benefits of Private Health Insurance
- Effect of the rebate on public hospital waiting
lists
- Private health insurance and sustainable affordability
in Australia
|
|
|
Dr Ian McPherson, Chief Executive Officer, Southern
Cross Healthcare, New Zealand
|
- Update on the role of private health insurance
in New Zealand
- The challenge of sustainability for Southern Cross
Health Fund
- Private health insurance innovations
- Medical savings accounts
- Implications for private health insurance in Australia
|
|
|
3
|
Chronically ill patients - Health fund approaches
to coordination of care and self management
|
Bruce Levy, Group Manager, Health Services, Medibank
Private
|
Chronic Care Initiatives at Medibank Private
- Medibank Private's approach to chronic care
|
Not Available
|
| Virginia Haggar, Director-Education, International
Diabetes Institute |
- A provider perspective
- The results of Medibank-on-Track Program - diabetes
management pilot
|
Not Available
|
| Keith Finney, General Manager, Provider
& Procurement, BUPA Australia Health |
- BUPA's approach to chronic care
- A clinician's perspective
- Patient perspective: how AuseMed has helped
|
TBA
|
|
4
|
Responses to providing
better quality health care at an affordable cost; The
potential for more effective use of data |
DR Martin Van Der Weyden, Editor, The
Medical Journal of Australia |
Safety in Australian Healthcare: who cares?
- The safety of Australian Health Care - QAHCS Study,
sentinel events, incidents and scandals
- The need for reform
- Clinical workforce shortages and health care financing
challenges
- Role of Australian Council for Quality & Safety
in Health Care
- Urgent areas for action
- Implications for private health insurance
|
Not Available
|
| The Hon DR Michael Wooldridge |
- The mixed public/private Australian health system
- Overview of Australian health and health service
indicators and international comparative data
- Using data to improve health services
- Barriers to linking data and establishing effective
databases in Australia
|
Not Available
|
| Professor Peter Collignon, Director, Infectious
Diseases Unit, The Canberra Hospital (Presentation
delivered by Professor Lindsay Grayson, Infectious Diseases
Department, Austin Health and Department of Medicine,
University of Melbourne) |
- The extent of health care associated infections
in Australian hospitals
- Staphylococcus aureus and MRSA
- Trends and outlook
- Clinical presentation of patients
- High risk patients
- National strategies for prevention
- Data collection and monitoring
- Impact on health care quality, patient outcomes
and costs
|
|
|
DAY TWO
|
|
5
|
An ageing Australia: Implications
for health expenditure and private health insurance |
Bernard Salt, Partner, KPMG |
- Demographic trends and an ageing Australia
- Current outlook
- Health expenditure and health insurance implications
|
|
| Rhonda Parker, Chief Executive, Positive
Ageing Foundation of Australia |
- Research findings on the impact of ageing
- Trends
- Healthy ageing
- Needs of mature people
- Services and programs to promote successful ageing
- Implications for health insurers
|
|
| Professor Allan McLean, Director, National
Ageing Research Institute |
- The biology of ageing
- Cause, prevention and cure of disease
- Consequences of ageing and its social accompaniments
- Lessons for health insurers
|
|
|
6
|
Musculoskeletal disease
and injury, treatment and rehabilitation |
Professor Stephen Graves, Director, Australian
Orthopaedic Assoc. National Joint Replacement Registry |
The Scope of Musculoskeletal Disease
- Treatment and Costs
- The scope of musculoskeletal disease
- Incidence, prevalence, extent of the disease
- Trends and implications for treatment and coverage
- Cost implications
- Patient management
- Joint replacement
- Improving health outcomes and reducing cost.
|
|
| DR Marlene Fransen, Senior Research Fellow,
Injury Prevention and Trauma Care, The George Institute
for International Health, University of Sydney |
- Extent of knee replacement operations in Australia
- Trends
- Demographics
- Post-operative recovery and rehabilitation outcomes
- Cost-effectiveness and scientific evidence
- Implications for private health insurance
|
|
|
7
|
Can we keep pharmaceutical costs affordable
and new medicines viable? |
Professor Andrew Wilson, Chair, Economic
Committee, Pharmaceutical Benefits Advisory Committee,
DoHA |
- Overview of the Pharmaceutical Benefits Scheme
- Special Access and High Cost Drugs
- Current coverage and expenditure
- Future trends
- Impact of new technologies and high cost drugs
- Drugs in the pipeline
- Role of PBAC
- Evaluation methods used in PBAC decision-making
- Implications for private health insurance
|
|
|
8
|
The ACCC view of key competition issues
impacting on the Private Health Sector |
John Martin, Commissioner, Australian
Competition and Consumer Commission |
- The ACCC approach to approval of recent large
merger proposals, such as Ramsay/Affinity
- Update on ACCC's monitoring of anti-competitive
practices impacting on private health insurance
- ACCC view of sustainable affordability and whether
hospital mergers and takeovers result in lower prices
for consumers
- Competition, health funds and the privatisation
of Medibank Private
- Future outlook for the private health sector from
the ACCC viewpoint
|
|